Ashwagandha for Sleep: What the Evidence Shows
By Abhi Wadhwa, Co-founder, EX1
Ashwagandha has meta-analysis-level evidence for sleep, clearest at 600 mg a day over eight weeks. Here is what the trials measured, and how to read a label.
Ashwagandha is one of the few botanicals whose sleep effect has been tested at the level of a meta-analysis, and that effect is clearest at a specific dose over a specific stretch of time. If you are comparing sleep supplements, the dose on the label and the length of the trial behind it are what separate a real signal from a hopeful one.
What the sleep research actually found
A 2021 systematic review in PLoS One pooled five randomised trials covering 400 adults and reported a small but significant improvement in overall sleep for ashwagandha root extract against placebo. The effect was more pronounced in people with diagnosed insomnia, and at higher doses over longer courses rather than in short trials.
An adaptogen is a plant traditionally used to help the body manage everyday stress. Ashwagandha is one, and the 2021 PLoS One review is the strongest single read on its sleep effect because it combines several trials rather than resting on one. It reported a genuine, if modest, improvement in sleep, and it was clear about where that improvement was strongest.
The dose and duration that mattered
In the pooled analysis, the clearer sleep effects appeared at 600 mg per day or more of a standardised root extract, taken for eight weeks or longer. Below that dose, or over a shorter course, the signal faded. Dose and duration, not the brand name on the bottle, are what tie a product to the studied result.
This is what to check on a label. A product that states a low dose, or that hides the extract strength behind a patent name with no standardisation percentage, cannot be matched to the 600 mg, eight-week evidence. The number and the weeks are the point.
Which parts of sleep changed
A 2020 trial in the Journal of Ethnopharmacology, run over eight weeks in healthy adults and people with insomnia, reported improvements in sleep-onset latency, sleep efficiency, and total sleep time, with the largest gains in the insomnia group. In plain terms, falling asleep sooner and spending more of the night actually asleep.
Sleep-onset latency is the time it takes to fall asleep once you are in bed. The 2020 Journal of Ethnopharmacology trial measured it falling significantly against placebo, alongside better sleep efficiency, the share of time in bed actually spent asleep. Those are the specific parts of sleep the research moved, rather than a vague sense of resting better.
How to read a sleep supplement: look for a standardised root extract, a stated dose at or above 600 mg per day, and evidence from a trial of eight weeks or longer. Ashwagandha is not a sedative and does not act like one. It is a daily adaptogen, and the research reflects a daily, multi-week pattern.
How EX1 fits
EX1 Ashwagandha is a 600 mg standardised root extract at 5% withanolides, taken once daily. That places it at the dose the sleep and stress trials above used, which is what lets you map the research onto what is in the bottle. Manufactured at WHO-GMP and AYUSH-GMP certified facilities with per-batch testing.
Related reading: How to read an ashwagandha label, and reading a magnesium label.